Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London · Delayed Price · Currency is GBP · Price in USD 17.93
-0.95 (-5.05%)
At close: Jul 15, 2025
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 1.82 billion as of July 16, 2025. Its market cap has decreased by -27.96% in one year.
Market Cap
1.82B
Enterprise Value
1.55B
Revenue
421.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.93
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 1.82B, an increase of 10,030.41%. That is a compound annual growth rate of 23.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.33B |
| GSK plc | 57.64B |
| Haleon | 32.99B |
| Smith & Nephew | 9.79B |
| ConvaTec Group | 5.29B |
| Hikma Pharmaceuticals | 4.35B |
| HUTCHMED (China) | 2.02B |
| Genus | 1.47B |